Allergy Relief
FDA Label NDC 11822-0713

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Rite Aid for the product Allergy Relief (NDC 11822-0713). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - do not use, otc - ask doctor, otc - when using, otc - stop use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active Ingredient (in each capsule)

Loratadine 10 mg

Otc - Purpose

Purpose

Antihistamine

Indications & Usage

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • itchy, watery eyes
  • sneezing
  • itching of the nose or throat

Warnings

Warnings

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Dosage & Administration

Directions

  • adults and children 6 years and over: 1 capsule daily; not more than 1 capsule in 24 hours
  • children under 6 years of age: ask a doctor
  • consumers with liver or kidney disease: ask a doctor

Other Safety Information

Other information

• store between 20-25°C (68-77°F)
• protect from freezing

Inactive Ingredient

Inactive Ingredients FD&C blue # 1, gelatin, (mono and diglyceride of caprylic/capric acid), pharmaceutical ink, polysorbate 80, povidone, purified water, sorbitol sorbitan solution

Package Label.Principal Display Panel

686t-riteaid-loratadine10mg-30ct-ifclabel (686t Riteaid Loratadine10mg 30ct Ifclabel)

686t-riteaid-loratadine10mg-30ct-ifclabel (686t Riteaid Loratadine10mg 30ct Ifclabel)

* Please review the disclaimer below.